Eiffage (FR:FGR) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Eiffage, in partnership with Fouchard and Sner, has secured a €72 million contract to expand and renovate the Henri Becquerel cancer treatment center in Rouen, France. Eiffage’s share of the project, which aims to enhance patient experience with sustainable and energy-efficient designs, is valued at €50 million. Construction has commenced with completion expected by 2026, ensuring continuous patient care during the process.
For further insights into FR:FGR stock, check out TipRanks’ Stock Analysis page.
